FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray LOGIN ABLAdvisor Blue
 
Skip Navigation LinksHome / News / Read News

Print

S&P Global Market Intelligence: Delayed Launches, Slow Sales Drive Drugmakers to Adapt Marketing Amid Pandemic

June 15, 2020, 09:10 AM
Filed Under: Pharmaceuticals

According to an article authored by Michael Gibney, Healthcare Reporter, S&P Global Market Intelligence and published by S&P Global Market Intelligence on June 15, 2020, for some biotech and pharmaceutical companies ready to send new drugs out into the world, the coronavirus pandemic has caused a shift in drug launch practices from face-to-face interactions to virtual communication.

To read the full article from S&P Global Market Intelligence, click here.







Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.

Sector/Economic Data
U.S. Census Bureau – U.S. Department of Commerce
March 2022 Construction Spending Report
U.S. Census Bureau – U.S. Department of Commerce
Full Report on Manufacturers' Shipments, Inventories and Orders - March 2022
view all sector/economic data
Featured Articles
The Legal Landscape in the Commercial Finance Industry
Two leading legal experts unpack the shifting landscape and address...
by Charlie Perer
The New Face of Sub Debt
As the commercial lending market evolves, non-bank sub-debt...
by Joseph Camberato
Most Popular | All Articles
Sponsored Content
CFG Merchant Solutions Underwriter Academy
CFGMS is proud to announce our new program: Underwriter Academy! Fast-track into a position with one of our producing underwriting teams.
sponsored by:
LEARN MORE